Biologically Active Peptides Derived from Peptide Hormones as Potential Drugs

A special issue of Pharmaceuticals (ISSN 1424-8247). This special issue belongs to the section "Biopharmaceuticals".

Deadline for manuscript submissions: closed (30 June 2022) | Viewed by 292

Special Issue Editor

Branch of Shemyakin and Ovchinnikov Institute of Bioorganic Chemistry, Science Avenue, 6, 142290 Pushchino, Moscow Region, Russia
Interests: peptides; receptors; drugs; signal transduction

Special Issue Information

Dear Colleagues,

Currently, biologically active peptides derived from natural peptide hormones are considered potential drugs of a new class. Such qualities of peptides as a quick reaction of the body to their introduction, almost complete absence of toxicity, as well as the fact that the products of peptide degradation are amino acids, are increasingly attracting the attention of pharmacologists and clinicians around the world. Unfortunately, the polyfunctionality of peptide hormones is a limiting factor in their use as drugs. Therefore, the main task in the design of new drugs based on natural peptide hormones is the synthesis of selectively acting analogs with a narrow spectrum of action that is resistant to enzymatic degradation. This requires a detailed description of the properties and mechanism of action of peptides as potential candidates for this role.

Prof. Dr. Elena V. Navolotskaya
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Pharmaceuticals is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • peptides
  • receptors
  • drugs
  • signal transduction

Published Papers

There is no accepted submissions to this special issue at this moment.
Back to TopTop